WASHINGTON — The two officials in charge of leading the Food and Drug Administration’s review of coronavirus vaccine applications will leave the agency this fall, according to an internal email announcing the departures, obtained by STAT.
The officials, Marion Gruber and Phil Krause, collectively have more than 42 years of experience at the FDA. Gruber has served as the director of the agency’s Office of Vaccines Research and Review since 2011, according to her LinkedIn profile. Krause has served as her deputy since 2010. Both were directly involved in managing the review of coronavirus vaccine applications.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.